Short Interest Reporting: AXIM BIOTECHNOLOGIES INCORPORATED (OTCMKTS:AXIM) Shorted Shares Increased 110% After Market Selling

November 25, 2016 - By Peter Erickson   ·   0 Comments

Short Interest Reporting: AXIM BIOTECHNOLOGIES INCORPORATED (OTCMKTS:AXIM) Shorted Shares Increased 110% After Market Selling

The stock of AXIM BIOTECHNOLOGIES INCORPORATED (OTCMKTS:AXIM) registered an increase of 110% in short interest. AXIM’s total short interest was 8,400 shares in November as published by FINRA. Its up 110% from 4,000 shares, reported previously. The stock decreased 18.13% or $1.36 on November 23, hitting $6.14. Axim Biotechnologies Inc (OTCMKTS:AXIM) has risen 1153.06% since April 22, 2016 and is uptrending. It has outperformed by 1147.65% the S&P500.

AXIM Biotechnologies, Inc., formerly Axim International, Inc., is a biotechnology company. The company has a market cap of $287.37 million. The Firm is engaged in developing the treatment of pain, spasticity, anxiety and other medical disorders with the application of cannabinoids products. It currently has negative earnings. It is focused on research, development and production of pharmaceutical, nutriceutical and cosmetic products, as well as procurement of genetically and nano-controlled active ingredients.

AXIM Company Profile

AXIM Biotechnologies, Inc., formerly Axim International, Inc., incorporated on November 18, 2010, is a biotechnology company. The Firm is engaged in developing the treatment of pain, spasticity, anxiety and other medical disorders with the application of cannabinoids products. The Firm is focused on research, development and production of pharmaceutical, nutriceutical and cosmetic products, as well as procurement of genetically and nano-controlled active ingredients.

More notable recent Axim Biotechnologies Inc (OTCMKTS:AXIM) news were published by: Globenewswire.com which released: “AXIM® Biotechnologies, Inc. Secures Funding to Continue Pharmaceutical …” on October 26, 2016, also Marketwatch.com with their article: “/quotes/zigman/3870025/realtime” published on May 20, 2013, Globenewswire.com published: “AXIM Biotechnologies, Inc. CEO to Speak on Emerging Markets and Cannabis Drug …” on October 19, 2016. More interesting news about Axim Biotechnologies Inc (OTCMKTS:AXIM) were released by: Globenewswire.com and their article: “AXIM Biotechnologies, Inc. CEO to Speak at First-Ever National Symposium on …” published on October 06, 2016 as well as Seekingalpha.com‘s news article titled: “Go Long Alternative Cannabis Consumption Methods?” with publication date: November 22, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Peter Erickson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>